ACTU · Actuate Therapeutics, Inc. · Documents
$1.07
-0.08 (-6.96%)
At close · Sep 11
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Based on the above matters, we have concluded that there is substantial doubt regarding the Company's ability to continue as a going concern.”View the 10-Q filed Aug 14, 2026
Market Cap
$25.70M
Shares
24.01M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 10-Q | 2026-08-14 | 2026-06-30 | |
| 8-K | 2026-07-17 | 2026-07-15 | |
| 8-K | 2026-05-22 | 2026-05-21 | |
| 10-Q | 2026-05-14 | 2026-03-31 | |
| 8-K | 2026-05-11 | — | |
| 8-K | 2026-05-06 | 2026-05-01 | |
| DEF 14A | 2026-04-06 | 2026-05-21 | |
| 10-K | 2026-03-26 | 2025-12-31 | |
| 8-K | 2026-01-12 | — | |
| 8-K | 2025-11-28 | — | |
| 8-K | 2025-11-21 | — | |
| 10-Q | 2025-11-13 | 2025-09-30 | |
| 8-K | 2025-09-10 | — | |
| 10-Q | 2025-08-14 | 2025-06-30 | |
| 8-K | 2025-06-26 | 2025-06-25 | |
| 8-K | 2025-06-05 | 2025-05-31 | |
| 8-K | 2025-06-02 | 2025-05-31 | |
| 8-K | 2025-05-23 | 2025-05-22 | |
| 10-Q | 2025-05-15 | 2025-03-31 | |
| 8-K | 2025-05-06 | — | |
| DEF 14A | 2025-04-08 | 2025-05-22 | |
| 8-K | 2025-03-28 | 2025-03-27 | |
| 10-K | 2025-03-13 | 2024-12-31 | |
| 8-K | 2025-02-07 | — | |
| 8-K | 2024-12-17 | — | |
| 10-Q | 2024-11-13 | 2024-09-30 | |
| 8-K | 2024-11-12 | — | |
| 10-Q | 2024-09-24 | 2024-06-30 | |
| 8-K | 2024-08-19 | — | |
| 8-K | 2024-08-14 | — |
Showing 1–30 of 30 filings